prodigiosin standard (MedChemExpress)
Structured Review

Prodigiosin Standard, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prodigiosin/Prodigiosin/pmc13234118-352-0-5
Average 94 stars, based on 2 article reviews
Images
1) Product Images from "A live biohybrid bacterial therapy based on engineered Serratia marcescens"
Article Title: A live biohybrid bacterial therapy based on engineered Serratia marcescens
Journal: Nature Communications
doi: 10.1038/s41467-026-70949-4
Figure Legend Snippet: a Bright-field and corresponding near-infrared (NIR, 808 nm excitation) images of S. marcescens colonies grown at 42, 37, and 30 °C. Similar results were obtained in 3 independent experiments. b Prodigiosin titer at 42 °C compared to 30 °C and 37 °C in LB plate. Data represent the mean ± SD of n = 3 biologically independent samples. Statistical significance was determined by a two-sided one-way ANOVA followed by Dunnett’s post-hoc test. Exact P values are indicated within the figure. c NIR emission spectrum of Prodigiosin upon 808 nm excitation, revealing broad emission spanning both NIR-I and NIR-II windows. d Time-resolved fluorescence decay curve of Prodigiosin, indicating a long fluorescence lifetime (τ_avg ≈ 1.2 µs). e Photothermal heating of bacterial suspensions (equivalent to 1, 2, and 5 mM prodigiosin) under continuous 808 nm laser irradiation (4.50 W/cm²). The thermal images demonstrate a rapid, concentration-dependent temperature increase. Similar results were obtained in 3 independent experiments. f Photothermal stability of a purified prodigiosin solution during four on/off cycles of 808 nm laser irradiation, showing excellent durability and consistent heating performance. g , h Validation of the thermal killing threshold for S. marcescens . g Representative images of spot-plated bacteria and h Quantitative CFU analysis of S. marcescens at different dilutions (1 × 10 11 , 1 × 10 10 , 1 × 10 9 CFU/mL) before and after a 3-min treatment at 60 °C. Data represent the mean ± SD of n = 4 biologically independent experiments. Statistical significance was determined by a two-sided unpaired Student’s t -test. Exact P values are indicated within the figure. i Agarose gel confirmation of msbB gene knockout. The first lane contains a DNA size marker (DL2000 Plus; bands from top to bottom: 2000, 1500, 1000, 750, 500, 250, and 100 bp). Lane SMM shows the PCR product from the parent strain (SMM), while lane SM confirms the successful gene deletion in the final theranostic strain. Source data are provided as a Source Data file.
Techniques Used: Fluorescence, Irradiation, Concentration Assay, Purification, Biomarker Discovery, Bacteria, Agarose Gel Electrophoresis, Gene Knockout, Marker
Figure Legend Snippet: a , b Confocal microscopy images showing the internalization of SM@CMC-KP101 by CT26 ( a ) and B16-F10 ( b ) tumor cells. DAPI staining (blue) indicates cell nuclei, and prodigiosin fluorescence (red) indicates the location of the bacteria. White arrows indicate bacteria within the cells. Scale bars: 50 µm (main panels), 10 µm (enlarged insets). Similar results were obtained in 3 independent experiments. c in vitro cytotoxicity of SM@CMC-KP101. Cell viability of CT26 and B16-F10 cell lines 8 h post-treatment with varying concentrations of SM@CMC-KP101. Data are presented as mean ± SD ( n = 3 per group). d Quantification of bacterial internalization efficiency in B16-F10 cells. Data represent the percentage of internalized bacteria for SMM, SM, SM@CMC, and SM@CMC-KP101. Data represent the mean ± SD of n = 3 independent experiments. Statistical significance was determined by a two-sided one-way ANOVA followed by Dunnett’s post-hoc test. Exact P values are indicated within the figure. e Flow cytometric analysis of bone marrow-derived dendritic cells (BMDCs) treated with PBS, ECN ( Escherichia coli Nissle 1917), SM-EV ( Serratia marcescens JC11 Δ msbB cultured under 42 °C, where the high-temperature environment resulted in the silencing of specific gene clusters, serving as a control for the empty vector), SM@CMC-KP101, or PG to assess BMDC activation (CD11c + CD80 + CD86 + ). The bar graph below shows the percentage of CD11c + CD80 + CD86 + cells for each treatment group. Data represent the mean ± SD of n = 3 independent experiments. Statistical significance was determined by a two-sided one-way ANOVA followed by Dunnett’s post-hoc test. Exact P values are indicated within the figure. f – i Relative mRNA levels of TNFα ( f ), iNOS ( g ), CD206 ( h ), and IL-10 ( i ) in BMDCs treated with PBS, ECN, SM-EV, SM@CMC-KP101 or PG, illustrating the immunomodulatory effects of each intervention. Data represent the mean ± SD of n = 3 independent experiments. Statistical significance was determined by a two-sided ordinary one-way ANOVA followed by Tukey’s multiple comparisons test. Exact P values are indicated within the figure. j Schematic representation of the proposed mechanisms of action of the SM@CMC-KP101 system. Created in BioRender. JI, L. (2026) https://BioRender.com/uma9zrk . All non-BioRender elements in this figure were independently created by the authors. Source data are provided as a Source Data file.
Techniques Used: Confocal Microscopy, Staining, Fluorescence, Bacteria, In Vitro, Derivative Assay, Cell Culture, Control, Plasmid Preparation, Activation Assay
Related Articles
Solvent:Article Title: Prodigiosin inhibits proliferation and metastasis in head and neck squamous cell carcinoma: insights from phenotypic validation and network pharmacology. Article Snippet: .. other:Article Title: Integrated stress response (ISR) activation and apoptosis through HRI kinase by PG3 and other p53 pathway-restoring cancer therapeutics Article Snippet: Chemicals: Prodigiosin was from NCI (National Cancer Institute); |
